Literature DB >> 26559842

Identification and Characterization of the Physiological Gene Targets of the Essential Lytic Replicative Epstein-Barr Virus SM Protein.

Jacob Thompson1, Dinesh Verma1, DaJiang Li1, Tim Mosbruger2, Sankar Swaminathan3.   

Abstract

UNLABELLED: Epstein-Barr virus (EBV) SM protein is an essential lytic cycle protein with multiple posttranscriptional mechanisms of action. SM binds RNA and increases accumulation of specific EBV transcripts. Previous studies using microarrays and PCR have shown that SM-null mutants fail to accumulate several lytic cycle mRNAs and proteins at wild-type levels. However, the complete effect of SM on the EBV transcriptome has been incompletely characterized. Here we precisely identify the effects of SM on all EBV transcripts by high-throughput RNA sequencing, quantitative PCR (qPCR), and Northern blotting. The effect of SM on EBV mRNAs was highly skewed and was most evident on 13 late genes, demonstrating why SM is essential for infectious EBV production. EBV DNA replication was also partially impaired in SM mutants, suggesting additional roles for SM in EBV DNA replication. While it has been suggested that SM specificity is based on recognition of either RNA sequence motifs or other sequence properties, no such unifying property of SM-responsive targets was discernible. The binding affinity of mRNAs for SM also did not correlate with SM responsiveness. These data suggest that while target RNA binding by SM may be required for its effect, specific activation by SM is due to differences in inherent properties of individual transcripts. We therefore propose a new model for the mechanism of action and specificity of SM and its homologs in other herpesviruses: that they bind many RNAs but only enhance accumulation of those that are intrinsically unstable and poorly expressed. IMPORTANCE: This study examines the mechanism of action of EBV SM protein, which is essential for EBV replication and infectious virus production. Since SM protein is not similar to any cellular protein and has homologs in all other human herpesviruses, it has potential importance as a therapeutic target. Here we establish which EBV RNAs are most highly upregulated by SM, allowing us to understand why it is essential for EBV replication. By comparing and characterizing these RNA transcripts, we conclude that the mechanism of specific activity is unlikely to be based simply on preferential recognition of a target motif. Rather, SM binding to its target RNA may be necessary but not sufficient for enhancing accumulation of the RNA. Preferential effects of SM on its most responsive RNA targets may depend on other inherent characteristics of these specific mRNAs that require SM for efficient expression, such as RNA stability.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26559842      PMCID: PMC4719603          DOI: 10.1128/JVI.02393-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression.

Authors:  V Ruvolo; E Wang; S Boyle; S Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

2.  Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.

Authors:  A Schepers; D Pich; W Hammerschmidt
Journal:  Virology       Date:  1996-06-15       Impact factor: 3.616

3.  Localization of the coding region for an Epstein-Barr virus early antigen and inducible expression of this 60-kilodalton nuclear protein in transfected fibroblast cell lines.

Authors:  M S Cho; K T Jeang; S D Hayward
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

4.  The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression.

Authors:  A K Gupta; V Ruvolo; C Patterson; S Swaminathan
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays.

Authors:  E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways.

Authors:  Brooke B Sahin; Denish Patel; Nicholas K Conrad
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

7.  Epstein-Barr virus protein EB2 contains an N-terminal transferable nuclear export signal that promotes nucleocytoplasmic export by directly binding TAP/NXF1.

Authors:  Franceline Juillard; Edwige Hiriart; Nicolas Sergeant; Valérie Vingtdeux-Didier; Hervé Drobecq; Alain Sergeant; Evelyne Manet; Henri Gruffat
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

8.  General and target-specific RNA binding properties of Epstein-Barr virus SM posttranscriptional regulatory protein.

Authors:  Zhao Han; Dinesh Verma; Chelsey Hilscher; Dirk P Dittmer; Sankar Swaminathan
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

9.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

10.  CAIcal: a combined set of tools to assess codon usage adaptation.

Authors:  Pere Puigbò; Ignacio G Bravo; Santiago Garcia-Vallve
Journal:  Biol Direct       Date:  2008-09-16       Impact factor: 4.540

View more
  7 in total

1.  Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.

Authors:  Wenmin Fu; Dinesh Verma; Ashlee Burton; Sankar Swaminathan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Epstein-Barr Virus Protein EB2 Stimulates Translation Initiation of mRNAs through Direct Interactions with both Poly(A)-Binding Protein and Eukaryotic Initiation Factor 4G.

Authors:  Fabrice Mure; Baptiste Panthu; Isabelle Zanella-Cléon; Frédéric Delolme; Evelyne Manet; Théophile Ohlmann; Henri Gruffat
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

3.  Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters.

Authors:  Dinesh Verma; Trenton Mel Church; Sankar Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-20       Impact factor: 11.205

4.  Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.

Authors:  Trenton Mel Church; Dinesh Verma; Jacob Thompson; Sankar Swaminathan
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 5.  An Epigenetic Journey: Epstein-Barr Virus Transcribes Chromatinized and Subsequently Unchromatinized Templates during Its Lytic Cycle.

Authors:  Adityarup Chakravorty; Bill Sugden; Eric C Johannsen
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

6.  Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.

Authors:  Dinesh Verma; Jacob Thompson; Sankar Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

7.  CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms.

Authors:  Reza Djavadian; Mitchell Hayes; Eric Johannsen
Journal:  PLoS Pathog       Date:  2018-06-04       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.